COPENHAGEN, Denmark, Sept. 6, 2023 /PRNewswire/ — Following convincing results from a recent In-Vitro study, the Danish biotech company, Tetra Pharm Technologies, today announces successful In-Vivo study results of its candidate compound, TPT0301. The In-Vivo study focuses on…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.